We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+8.33%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$7.07B
AUM Growth
-$2.18B
Cap. Flow
-$2.47B
Cap. Flow %
-34.87%
Top 10 Hldgs %
22.16%
Holding
3,861
New
1,138
Increased
540
Reduced
516
Closed
1,413

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MCK icon
McKesson
MCK
+$132M
3
TSLA icon
Tesla
TSLA
+$88.8M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$72.7M
5
CSCO icon
Cisco
CSCO
+$57.5M

Sector Composition

Rank Sector Weight
1 Technology 17.97%
2 Financials 10.47%
3 Healthcare 9.77%
4 Consumer Discretionary 8.51%
5 Industrials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTAW
2176
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$20K ﹤0.01%
40,814
-2,625
-6% -$1.68K
LVWR.WS icon
2177
LiveWire Group Warrants
LVWR.WS
$5.09M
$20K ﹤0.01%
74,933
BODI icon
2178
The Beachbody Company
BODI
$74.8M
$20K ﹤0.01%
796
-186
-19% -$8.07K
LTRPA
2179
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$20K ﹤0.01%
+30,635
New +$28.8K
SMFL
2180
DELISTED
Smart for Life, Inc. Common Stock
SMFL
$20K ﹤0.01%
28
+22
+367% +$25.8K
BBIG
2181
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$20K ﹤0.01%
+2,252
New +$34.6K
BOXD
2182
DELISTED
Boxed, Inc.
BOXD
$20K ﹤0.01%
+106,549
New +$54.4K
ABLLW
2183
DELISTED
Abacus Life Warrant
ABLLW
$19K ﹤0.01%
110,476
+99,790
+934% +$14.7K
CARM
2184
DELISTED
Carisma Therapeutics
CARM
$19K ﹤0.01%
+1,619
New +$17K
BIOL
2185
DELISTED
Biolase, Inc.
BIOL
$19K ﹤0.01%
+303
New +$43.6K
HEPS
2186
D-Market Electronic Services & Trading
HEPS
$990M
$18K ﹤0.01%
+27,751
New +$20.4K
SONN
2187
DELISTED
Sonnet BioTherapeutics
SONN
$18K ﹤0.01%
+91
New +$19.9K
NNAVW
2188
DELISTED
NextNav Inc Warrant
NNAVW
$17K ﹤0.01%
43,940
PSNYW icon
2189
Polestar Automotive Holding ADS Class C-1
PSNYW
$387M
$17K ﹤0.01%
529
+48
+10% +$1.5K
RNAZ icon
2190
TransCode Therapeutics
RNAZ
$4.19M
0
BRLIR
2191
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$17K ﹤0.01%
94,171
AGILW
2192
DELISTED
AgileThought Inc Warrant
AGILW
$17K ﹤0.01%
43,160
-4,996
-10% -$2.06K
ADERW
2193
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$17K ﹤0.01%
68,327
+25,506
+60% +$7.4K
XBIO icon
2194
Xenetic Biosciences
XBIO
$7.26M
$16K ﹤0.01%
+5,647
New +$24.9K
UP icon
2195
Wheels Up
UP
$198M
$15K ﹤0.01%
76
-1,093
-93% -$282K
WALDW icon
2196
Waldencast PLC Warrant
WALDW
$4.21M
$15K ﹤0.01%
24,970
ATHX
2197
DELISTED
Athersys, Inc. Common Stock
ATHX
$15K ﹤0.01%
+17,879
New +$22.3K
PHUN icon
2198
Phunware
PHUN
$43.6M
$14K ﹤0.01%
369
+21
+6% +$1.14K
THCHW
2199
DELISTED
TH International Limited Warrant
THCHW
$14K ﹤0.01%
117,491
PLXP
2200
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$14K ﹤0.01%
+86,942
New +$36.4K

Similar funds

HRT Financial's Q4 2022 Portfolio in Review

As of Q4 2022, HRT Financial held 3,861 positions worth $7.07B, down 24% from $9.25B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

HRT Financial withdrew a net $2.47B in Q4 2022, closing 1,413 positions and reducing 516 holdings. Its most notable exit was Duke Realty Corp., an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, HRT Financial opened a new position in Apple worth $206M.

  • HRT Financial's largest Q4 2022 buy was Apple: 1,584,749 shares worth $206M.
  • HRT Financial added most to Cisco in Q4 2022, an estimated $57.5M increase.
  • HRT Financial's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $628M.
  • HRT Financial fully exited Duke Realty Corp. in Q4 2022, selling an estimated $214M.
  • HRT Financial's ten largest holdings make up 22% of its $7.07B portfolio in Q4 2022.
  • HRT Financial opened 1,138 new positions and closed 1,413 in Q4 2022.
  • HRT Financial's portfolio value fell 24% quarter-over-quarter to $7.07B.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.